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INTRODUCTION 
Amniotic fluid serves several functions, such as providing a medium for fetal 
growth and development, protecting the fetus from external trauma, and maintaining 
intrauterine temperature. 
Meconium stained amniotic fluid occurs in 12-20 % of all pregnancies. In 
the past it was considered as a sign of fetal distress occurring only in response to 
hypoxia. 
But in most cases, meconium in amniotic fluid is benign and associated with 
term pregnancies. While there is a general agreement that the presence of 
meconium stained amniotic fluid is associated with increase in perinatal mortality 
and morbidity, many investigators do not believe that presence of meconium 
predicts a poor outcome unless it is accompanied by other signs of fetal distress 
However, if aspirated by the fetus before or during birth, meconium can 
obstruct the airways, interfere with gas transfer and cause respiratory difficulties. 
The increased perinatal mortality and morbidity in the presence of meconium 
stained amniotic fluid is mainly due to meconium aspiration syndrome, which occurs 
in 2-10% of these neonates. 50-60% of infants whose amniotic fluid was meconium 
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stained was reported to have  meconium in  their  tracheas.  Treatment strategies of 
deep suctioning of hypo pharynx and nares during delivery and immediate tracheal 
suctioning after birth have been successful in reducing meconium aspiration 
syndrome. But despite aggressive airway clearing, meconium aspiration syndrome 
is not always prevented, the causative factor being in utero aspiration. 
Amnioinfusion dilutes the amniotic f luid and has been studied as an 
additional tool to prevent meconium aspiration. It helps by physical dilution of the 
thick meconium and thereby decreasing the toxic effects of aspiration of thick 
meconium. It also increases the fluid around the fetus and thereby decreases cord 
compression and hence fetal hypoxia when present. 
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AIM OF THE STUDY 
Evaluation of intrapartum transcervical amnioinfusion as a therapeutic 
procedure for moderate and thick meconium stained amniotic fluid and its 
impact on 
1.     The incidence of intrapartum foetal heart abnormalities. 
2.      The  incidence of intrapartum operative interventions. 
3.      Neonatal outcome by Apgar score at 1 minute and 5 minutes. 
4.      Incidence of meconium below the vocal cords by direct     
laryngoscopy. 
5.      Incidence of meconium aspiration syndrome. 
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REVIEW OF LITERATURE 
In 1976 Gabbe3 and coworkers demonstrated in a rhesus monkey that 
removal of amniotic fluid produced variable deceleration and the replenishment 
of fluid with saline relieved the deceleration. 
In 1983 Miyazaki and Taylor6 infused saline through intra uterine 
pressure catheter to women in labour who had either variable deceleration or 
prolonged deceleration attributed to cord entrapment. They found that this 
improved heart rate pattern in half the patients. 
In 1985 Miyazaki and Nevarez7 randomized 96 pregnancies and found 
multiparous women in labour with cord compression pattern who were treated 
with amnioinfusion less often-required caesarean delivery for foetal distress. 
In 1978 Meis et al5 evaluated patients with meconium passage in early and 
late labour and graded the presence of meconium as light or heavy. Heavy 
meconium passage in early labour was associated with increased foetal 
morbidity including abnormal foetal heart pattern, prolonged second stage of 
labour and increased operative interventions. It was also associated with higher 
incidence of neonatal morbidity and mortality. 
Carson et al4 1976 described combined obstetric and pediatric approach 
to infants tracheal suctioning at delivery. 
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Wenstrom et al8 1989 randomly compared 85 patients with thick 
meconium.  The study group was infused with 1000ml normal saline solution 
initially and every 6 hours until delivery. Control patients received routine 
management .The incidence of low 1 minute Apgar score, meconium below the 
vocal cords and operative delivery were significantly less in patients receiving 
amnioinfusion. They noted that amnioinfusion is a simple inexpensive and safe 
technique that reduces the incidence of meconium below cords and improves 
the obstetric outcome in patients. 
Sadovsky et al91989 demonstrated that 19 cases of labour treated with 
amnioinfusion for thick meconium had a better neonatal outcome compared with 
21 cases treated routinely. The frequency of neonatal acidemia and positive 
pressure ventilation was significantly reduced in the infused group. 
In 1990 Posner MD et al10. did a study on the effect of amnioinfusion on 
uterine pressure and activity and reported that a significant increase in uterine 
tone was noted during and after the infusion.  
In 1992 Charles J et al14 studied 170 term and post term patients with thick 
meconium chosen to receive amnioinfusion or standard obstetric care without 
amnioinfusion. The rate of foetal distress,caesarean section for foetal distress 
and rate of meconium aspiration syndrome were significantly reduced with 
amnioinfusion. 
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Eriksson and colleagues22 in 1994 found that amnioinfusion in 
pregnancies complicated by thick meconium stained amniotic fluid reduced the 
risk of meconium below the cords and respiratory distress in newborn. 
Lo et al20 in 1993 and Cialone et al23 in 1994 reported a reduced frequency 
of acidemia, meconium aspiration syndrome and other neonatal complications 
in conjunction with amnioinfusion in the setting of thick meconium. 
In 1996 Ou Zounian JG et al28 did retrospective study to evaluate the use of 
intrapartum amnioinfusion in women undergoing a trial of labour after a previous 
cesarean delivery and concluded that amnioinfusion appears to be an acceptable 
procedure in women with previous cesarean births.   
Hofmeyer et a/34 1998 for the Collaborative Randomized Amnioinfusion 
for Meconium Project (CRAMP1) South Africa did a multicentre randomized 
controlled trial and found that amnioinfusion for meconium stained amniotic 
fluid reduces the incidence of meconium aspiration syndrome. 
Mahomed et a/35 1998 (CRAMP 2) Zimbabwe found that meconium 
aspiration syndrome was significantly less frequent in amnioinfusion group and 
there was trend towards fewer perinatal deaths. In the same study there was no 
difference in the rate of caesarean section. 
In 1999 Edwards RK et al37did randomized study about prophylactic cefazolin 
in amnioinfusion administrate for meconium stained amniotic fluid and concluded that 
prophylactic use of cefazoline in Amnioinfusion did not significantly reduce the  rates 
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of maternal or neonatal infection in patients with meconium stained amniotic fluid.  
John Pierce et al39 2000 did a Meta analysis of 13 prospective clinical 
trials of intrapartum amnioinfusion for meconium stained fluid. They reached a 
conclusion that amnioinfusion significantly reduced the frequency of meconium 
aspiration syndrome, meconium below the vocal cords and neonatal acidemia. 
The overall caesarean delivery rate was also significantly lower without 
increased postpartum endometritis. 
In 2000 Ask AK40 said amnioinfusion can be an effective preventive 
measure for managing patients with meconium stained amniotic fluid. 
Vinita Das et al41 did a prospective case control study in 2001 regarding 
the safety and efficacy of amnioinfusion during labour complicated by 
meconium stained liquor and found that amnioinfusion decreases the cesarean rate, 
incidence of meconium aspiration syndrome and perinatal mortality. 
In 2001 Wiswill TE42 proposed that antenatal therapies should include 
amnioinfusion, intrapartum maneuvers should include oropharyngeal suctioning 
prior to delivery of the baby’s shoulders,  the postnatal intervention of intubation 
for intratracheal suctioning should be reserved for the non-vigorous meconium 
stained infant.  
In 2001, Puertas A, et al43 did randomized trial of prophylactic 
amnioinfusion and concluded that  amnioinfusion improves the neonatal outcome 
and reduces the frequency of caesarean sections. 
A.M Rathor et al44 in 2002 did a randomized controlled trial in 200 women 
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and found that caesarean section rate in amnioinfusion group was less than 
control group and amnioinfusion was associated with significant decrease in the 
incidence of meconium at vocal cords, improvement in one minute Apgar score, 
respiratory distress and fewer admissions to NICU compared with that of controls. 
In 2002 Gonzalez JL et al45 did prospective randomized study using normal 
saline or ringer lactate solution for amnio infusion in women with thick meconium 
in the amniotic fluid.  Cord blood arterial sampling was analysed for sodium, 
potassium and chloride plasma concentrations and PH.  There was no significant 
difference in cord blood arterial plasma concentrations  of  Sodium, Potassium, 
Chloride and PH. 
Sood M46 Charulatha,  Dimple, Aggarval N, Faridi MM, did randomized 
controlled  trial in  2004 regarding amnioinfusion in thick meconium and found that 
amnioinfusion resulted  in relief of deceleration and significant reduction in the 
incidence of meconium below the vocal cord and concluded that transcervical 
intrapartum amnioinfusion is a safe, simple and inexpensive technique that reduces 
operative intervention and improves neonatal outcome, and is of tremendous value  
in developing countries.     
In 2004, Ashfaq F47, Shah AA did controlled clinical trial of effect of 
amnioinfusion for meconium stained amniotic fluid on perinatal outcome and 
found that the amnioinfusion significantly decreased the cesarean rate, perinatal 
mortality and morbidity, meconium aspiration syndrome, neonatal admission in 
NICU.  
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In 2006,  Parth Mukhopadhyay51, Tapan Naskar,  Rabindranath Dalui, did 
a study about role of intrapartum amnioinfusion  in meconium stained amniotic 
fluid and found that amnioinfusion decreases the incidence of cesarean rate owing 
to fetal distress, decreases the meconium in the treachea, reduces the incidence of 
to meconium aspiration syndrome and birth asphyxia. 
In 2006, ACOG Committee50 Obstetric practice  said that routine prophylactic 
amnioinfusion  for the dilution of amnioinfusion for meconium stained amniotic 
fluid should be done only in the setting of additional clinical trials.  However, 
amnioinfusion remains a reasonable approach in the treatment of repetitive variable 
decelerations, regardless of amniotic fluid meconium status.  
Cochrane database48 2006 says amnioinfusion is associated with a reduction 
in heavy meconium staining of liquor, variable fetal heart deceleration and 
reduced caesarean section. Also associated with reduction in meconium 
aspiration syndrome, neonatal hypoxic ischaemic encephalopathy and neonatal 
ventilation or NICU admission. The database also showed a trend towards reduced 
perinatal mortality. It concluded that amnioinfusion is associated with 
improvement in perinatal outcome particularly in settings where facilities for 
perinatal surveillance are limited. 
In 2006, Velaphi49 S. Vidyasagar D provides  evidence based 
recommendations regarding the benefits of amnioinfusion prior to delivery, oral 
suctioning of the new born prior to delivery of the shoulder and the practice of 
routine endotrachaeal suctioning of the newborn born through meconium stained 
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amniotic fluid in preventing meconium aspiration syndrome.  
In 2007 Das AK,52 Jana N, Das Gupta S, Samanta B did  prospective 
comparative  study  about the effect of amnioinfusion in meconium stained 
amniotic fluid   and found that amnio infusion significantly reduced the incidence 
of low APGAR score, meconium aspiration syndrome, incidence of cesarean 
deliveries and perinatal death.  
In 2007, XUH, Hofmeyr J et al53 did randomized  trials comparing 
amnioinfusion  with no amnioinfusion for women in labour with meconium 
stained amniotic fluid and found that in clinical settings with standard peripartum 
surveillance the evidence does not support the use of amnio infusion for 
meconium stained amniotic fluid.  In settings with limited peripartum 
surveillance, when complications of meconium stained amniotic fluid are 
common, amnioinfusion appears to reduce the risk of meconium aspiration 
syndrome. 
Amnioinfusion is technically  feasible even in developing countries with 
limited intrapartum facility. 
AMNIOINFUSION-GENERAL CONSIDERATIONS 
Definition 
Amnioinfusion is a procedure in which a physiologic solution [such as 
normal saline] is infused into the amniotic cavity. There are three predominant 
indications56 for which amnioinfusion has been used: 
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1) Intrapartum amnioinfusion for meconium stained amniotic fluid. 
2) Treatment of variable or prolonged decelerations. 
3) Amnioinfusion for oligohydramnios. 
AMNIOINFUSION FOR OLIGOHYDRAMNIOS 
Transabdominal amnioinfusion has been attempted for diagnostic 
purposes in women with second or third trimester oligohydramnios. 
 Instillation of saline will improve the sonological visualization16    and 
more accurate diagnosis of congenital anomalies or IUGR in case of 
oligohydramnios. 
In addition to this, repeated trans abdominal amnioinfusions in patients 
with normally grown fetus but persistent oligohydramnios would prevent 
pulmonary hypoplasia and compression defects12. 
INTRAPARTUM AMNIOINFUSION FOR VARIABLE 
DECELERATIONS 
Many reports24 have documented relief of variable decelerations with 
trans vaginal amnioinfusion. Presumably more fluid is associated with less cord 
compression and thus relieves the variable decelerations, which occur due to  
cord compression6. 
INTRAPARTUM AMNIOINFUSION FOR MODERATE OR 
THICK MECONIUM STAINED AMNIOTIC FLUID 
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Multiple randomized studies23,34,35 have reported that amnioinfusion for 
moderate or thick meconium stained amniotic fluid is associated with a 
significant decrease in meconium aspiration.  
For amnioinfusion either Ringer lactate or Normal saline can be used, the 
type of solution used has not shown to affect the outcome. These solutions do 
not cause any electrolyte imbalance in the fetus45. 
Glantz and Letteney30 compared using warmed [370C] versus room 
temperature infusions; they found no difference in the outcome. They also 
compared using infusion pump versus gravity and found both to be equally 
effective. 
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Several protocols have been described for amnioinfusion: 
1. An initial bolus of 500-600ml in 30-60 minutes followed by a maintenance 
rate of 3ml/minute till delivery. 
2. An initial bolus of 500-600ml in 30-60 minutes. Repeat the dose after 4 hours 
if delivery does not occur.  
The protocol used in this study was to infuse 500ml of normal saline as 
initial bolus dose over 30 minutes, followed by 500ml more at a rate of 2-3 
ml/minute. The use of maximum 1 liter was considered safe due to lack of 
accurate intrauterine pressure monitoring or cardiotocographic monitoring41. 
RISKS AND COMPLICATIONS OF AMNIOINFUSION 
Reported complications include uterine hypertonus, fetal heart rate 
abnormalities, chorioamnionitis, uterine rupture, placental abruption and maternal 
cardiac and respiratory failure24  
Maher et al25  reported two cases of amniotic fluid embolism in women 
when an amnioinfusion by infusion pump was ongoing. Several authors have 
reported the occurrence of excessive uterine contractions  or  unusually  rapid   
progress  of labour associated  with amnioinfusion. 
There is a hypothesis that excessive uterine contractions in some cases are 
related to extra amniotic placement of amnioinfusion catheter with simultaneous 
prostaglandin release38  Rapid absorption of the infused fluid could account for the 
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reported cases of pulmonary edema. Consensus of reported data suggest that 
there is no increased risk of maternal and neonatal infection with 
amnioinfusion. Owen et al11 noted decrease in endometritis in women with 
amnioinfusion compared with those in control. 
NEONATAL CARE FOLLOWING AMNIOINFUSION  
Assuming that most of the meconium aspiration occurs at first neonatal 
breath, Carson4 and associates (1976) reported that suction of fetal nasopharynx 
immediately after delivery of the head but before the delivery of the shoulders 
combined with tracheal intubation and suction was effective in reducing the 
incidence and severity of meconium aspiration. 
But Suresh and Sarkar (1994) noted that despite careful suctioning and 
absence of neonatal breathing before intubation, 75% still had meconium at 
trachea. 
The current view is that meconium aspiration occurs due to fetal breathing 
movements, causing inhalation of amniotic fluid with meconium. The 
breathing movements, which cause inhalation of amniotic fluid, are of two types: 
gasping and deep breathing54. 
Gasping is a normal response to hypoxemia and can be induced 
experimentally by occluding the umbilical cord or by occluding the maternal 
aorta. 
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The fetus may also inhale meconium by deep irregular breathing in 
utero, not initiated by hypoxia. These breaths become more frequent as 
gestation advances, and comprise 10% of all fetal breathing movements. Fetal 
hypercapnoea and acidemia also increase these breathing movements but they 
still occur in most if not all normal fetuses54. 
Thick meconium is viscid enough to obstruct neonatal airway and 
concentrated enough to cause significant chemical injury to tissues. Starks 
(1980) found that thick meconium was associated with a higher percentage of 
low Apgar scores. Mahomed and colleagues (1994) reported that patients with 
thin meconium had outcomes indistinguishable from those with clear fluid. 
Amnioinfusion dilutes the meconium and this reduces the toxic effects 
due to aspiration of thick meconium. It also increases the volume of fluid 
around the fetus, thereby decreasing the possibility of fetal distress related to cord 
compression6  
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SIGNIFICANCE OF  MECONIUM  PASSAGE  IN UTERO 
Meconium, an odorless thick blackish green material is first demonstrable 
in the fetal intestine during the third month of gestation. It is an accumulation of 
debris that consists of desquamated cells from the alimentary tract and skin, 
lanugo hairs, fatty material from vernix caseosa, amniotic fluid, and various 
intestinal secretions. 
The quantity of meconium in fetal gut is small during the first two 
trimesters, but increases rapidly during the third. Because the internal and 
external anal sphincters are usually closed during fetal life, amniotic fluid 
ordinarily remains clear. Various stimuli however are known to cause relaxation 
of sphincter tone and subsequent passage of meconium into the amniotic fluid. 
It is widely believed that any insult causing hypoxia in fetus will cause 
fetal hyper peristalsis and relaxation of the fetal anal sphincter55. However as 
Hon suggested parasympathetic stimulation from cord compression may 
stimulate meconium passage without concomitant hypoxia. 
It is also possible that meconium is passed as a result of spontaneous 
gastro intestinal motility that reflects physiologic maturation of fetal gut. As the 
vast majority of fetuses have no acid base abnormality, the presence of meconium 
itself is not a sensitive or specific indicator for fetal compromise54. 
A number of studies have failed to show any consistent effects of 
meconium stained amniotic fluid on Apgar scores, fetal scalp pH or incidence of 
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fetal heart rate abnormalities. (Abramnici et al 1974; Miller et al 1975; Baker et 
al 1992). Moreover one study found that although meconium stained amniotic 
fluid correlated poorly with markers of acute intrauterine asphyxia, (pH, 
lactate, hypoxanthine concentration) it correlated well with blood erythropoietin 
concentration (marker of chronic asphyxia)55 . 
Despite these theories, most obstetricians agree that meconium stained 
amniotic fluid in connection with fetal heart rate abnormalities is a marker for 
fetal distress and is associated with increased perinatal morbidity and mortality. 
MECONIUM ASPIRATION SYNDROME 
Whatever be the stimulus, once meconium has been passed, any episode, 
either fetal gasping or respiratory attempts by the foetus can cause aspiration of 
amniotic fluid containing meconium into the fetal tracheo bronchial tree. 
Meconium aspiration thus occurring can obstruct the airway; interfere with gas 
exchange and cause severe respiratory distress. 
Meconium aspiration syndrome can occur in 10% of cases with 
meconium stained amniotic fluid. It comprises a significant range of respiratory 
compromise. In its mildest form55, the disease may present with neonatal 
tachypnoea associated with normal pH and lower pCO2, which resolves within 
2-3 days. Clinically this mild respiratory morbidity may be indistinguishable 
from transient tachypnoea of newborn. In the more severe form, the syndrome 
can present as severe hypoxemia, acidosis, pnuemothorax and respiratory failure a 
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few hours after birth. Pulmonary arterial vasospasm may lead to right to left 
shunting through patent foramen ovale or ductus arteriosus. Hypoxia further 
stimulates pulmonary hypertension and the downward spiral continues ultimately 
leading to convulsions, renal failure, disseminated intravascular coagulation and 
heart failure. 
Clinically the infants with meconium aspiration syndrome can have 
evidence of over inflation of lungs, with a barrel chest. Auscultation can reveal 
diffuse crepitations and rhonchi. The chest radiograph shows patchy areas of 
atelectasis and areas of over inflation. Pnuemothorax and pnuemomediastinum 
are common (10-20% Peters and Pendleton 1989). Pleural effusion may be 
present in about 30%. But the severity of chest x-ray abnormalities may not 
correlate with the severity of clinical disease. 
PATHOPHYSIOLOGY 
The pathophysiology of meconium aspiration is extremely complex due 
to interplay of a large number of mechanisms. Perinatal asphyxia is a critical 
underlying factor in the pathogenesis of meconium aspiration syndrome. The 
pulmonary abnormalities in meconium aspiration syndrome are related primarily 
to acute airway obstruction, with obstructive emphysema due to ball valve effect. 
Due to the direct irritation and toxicity of meconium constituents, there is 
a marked alveolar and parenchymal inflammation and edema with leakage of 
proteins into the airways. There is release of inflammatory mediators like 
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cytokines. Meconium adversely affects the neutrophil function by inhibiting 
phagocytosis with increased risk of infections. Surfactant dysfunction may occur 
due to cytotoxic effect on type 2 pnuemocytes and decreased level of surfactant 
proteins A and B. there is increased airway resistance and reduced compliance of 
lungs. 
Pulmonary vasoconstriction occurs due to injury of the vascular bed of 
the lung. In these infants, vascular smooth muscle extends into the walls of 
normally non-muscular intra acinar arterioles and reduces their luminal diameter, 
which subsequently interferes with normal postnatal drop in pulmonary vascular 
resistance. In addition these infants may demonstrate plugs of platelets in their 
small vessels which reduces the cross sectional area of the pulmonary vascular bed. 
MANAGEMENT OF INFANT DELIVERED THROUGH MECONIUM 
STAINED AMNIOTIC FLUID 
In all cases of meconium stained amniotic fluid, obstetrician should do 
the suction of oropharynx, mouth and nose as soon as the head of the baby is 
delivered. 
 
In 1974, a prospective study by Gregory et al1 recommended 
laryngoscopy and tracheal intubation with suctioning for all newborns born 
through thick particulate meconium. In 1976 Carson et al4 reported a decrease 
in meconium aspiration syndrome with suctioning of hypopharynx before the 
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shoulders were delivered and before the first postnatal breath. They 
recommended routine tracheal suctioning after this was not necessary unless 
meconium was visible at vocal cords or hypopharynx. Many studies (Wisewell  
et al17 Hageman et el; Strickland et al) have shown beneficial effects of 
aggressive airway management. 
In contrast AAP18 guidelines of perinatal care recommends endo tracheal 
intubation and direct tracheal suction only if there is meconium at the larynx on 
laryngoscopy and the infant is depressed. 
But the study by Wiswell17 showed that as many as 41-54% of infants in 
whom meconium aspiration syndrome developed had Apgar score of 8 or 
greater. Thus a vigorous baby can still develop meconium aspiration syndrome. 
So the current management is for any infant delivered with thick meconium 
stained amniotic fluid: place in radiant warmer, immediate intubation and 
suction of trachea via ETT with meconium aspirator, repeat the suction till clear, 
assess for respiratory distress, and empty the stomach contents18
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Meconium Stained Fluid Detected18
È 
Notify person skilled in neonatal resuscitation and capable of ET intubation 
available 
È 
Suction mouth and nasopharynx prior to delivery of the shoulders 
Place infant on radiant warmer in Trendelenburg 
È 
Thick or Particulate Meconium 
Immediately intubate and suction trachea via ETT with meconium aspirator. 
Repeat until clear 
È 
Assess for respiratory distress and 
Further management for MAS. 
Empty stomach contents 
MANAGEMENT OF MECONIUM ASPIRATION SYNDROME 
Symptomatic infants with meconium suction from the trachea should be 
given chest physiotherapy and warm humidified oxygen to breathe. Due to high 
incidents of air leaks, positive pressure of ventilation must be avoided if 
possible. Mechanical ventilators should be used for infants with apnoea from 
birth asphyxia or for those infants who cannot maintain their PaO2 >50mm Hg 
in 100% Oxygen55. 
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As meconium aspiration pneumonia is an obstructive lung disease the time 
constant for expiration is prolonged in severely involved areas of lungs. Careful 
attention must be given to expiratory type to prevent inadvertent PEEP, further 
gas trapping and alveolar rupture. 
Meconium enhances bacterial growth by reducing the host resistance55. But 
no studies confirm that infection plays a role in the pathogenesis of meconium 
aspiration syndrome. Since there is difficulty indistinguishing meconium 
aspiration syndrome from bacterial pneumonitis, many routinely treat infants 
with having meconium aspirations with antibiotics. 
The use of corticosteroids for treating meconium aspiration syndrome is 
not recommended. The time taken for weaning to room air is prolonged with the 
use of steroids55
As discussed earlier there is evidence that infants with meconium 
aspiration syndrome have surfactant inactivation. Trials have found that 
surfactant replacement therapy if started within six hours of birth improve 
oxygenation,  reduces air leaks, reduces pulmonary morbidity and shortens 
hospital duration of stay. (Findly et al I996). 
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MATERIALS AND METHODS 
The Study was conducted at Govt RSRM Lying-in Hospital from 
September 2006 to August  2007. For this prospective randomized controlled 
clinical trial, participants were 200 women in labour at term with moderate or 
thick meconium stained amniotic fluid.  
Inclusion Criteria 
1) Singleton pregnancy 
2) Vertex presentation 
3) Gestational age between 37 and 41 weeks 
4) Normal fetal heart rate with regular rhythm. 
5) Having moderate or thick meconium stained amniotic fluid on 
spontaneous rupture of membranes or after doing artificial rupture of 
membranes in labour ward. 
Exclusion criteria 
1) Fetal malpresentations 
2) Multiple gestations. 
3) Fetal congenital anomalies. 
4) Prelabour rupture of membranes. 
5) Polyhydramnios. 
6) Chorioamnionitis. 
7) Antepartum hemorrhage. 
8) Medical diseases complicating pregnancy.  
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Procedure  
Each patient was carefully examined to rule out any risk factor, 
confirmation of gestational age was done by detailed menstrual history, 
clinical examination and previous scan report if the patient had taken already.  
Abdominal examination was done and fetal presentation determined. 
Duration and frequency of uterine contractions were assessed. The fetal heart 
rate was auscultated with Pinard Foetoscope.  
Vaginal examination was done to assess the stage of labour and to 
confirm the presentation. The amniotic fluid was examined after spontaneous or 
artificial rupture of membranes and graded as follows : 
Grade I thin meconium: having uniform greenish staining and watery. 
Grade  II  moderate:  having thicker greenish  staining but still watery. 
GradeIII thick meconium: Green with particulate matter having pea soup 
quality. [Thick tenacious and opaque] 
These patients were categorized into amnioinfusion and no 
amnioinfusion group in a 1: 1 ratio i.e. the first patient was given 
amnioinfusion, whereas the second patient was taken as control group [without 
amnioinfusion]. Procedure was explained to the patient and consent obtained. 
In the amnioinfusion group patient was asked to lie in dorsal position and 
an autoclaved rubber catheter was introduced transcervically under aseptic 
precautions so that its tip lies just above the baby's head. Normal saline at room 
temperature was infused through the catheter using intravenous tubing. 
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The amnioinfusion started with an initial bolus of 500 ml normal saline 
infused over 30 minutes. Then 500 ml more was infused at a rate of 30-45 drops 
[2-3ml] per minute. The use of maximum one litre was considered safe. The 
control group received no catheter placement. Both groups were then managed 
in labour ward according to routine policy. 
Uterine tone and frequency of contractions were assessed by abdominal 
palpation. Oxytocin drip was started if contractions were not effective. Fetal 
heart rate was auscultated every 15 minutes during the first stage of labour and 
every 5 minutes during the second stage using Pinard foetoscope. Fetal distress 
was defined as fetal bradycardia [<120 beats / minute] or fetal tachycardia 
[>160 beats / minute]. 
Progress of the labour was monitored and obstetric assistance was given 
whenever necessary. Forceps application or delivery by caesarean section was 
done for fetal heart rate abnormalities or failure to progress such as arrest 
disorders or protraction disorders as indicated. 
During delivery as soon as baby's head was delivered, the eyes were 
cleaned and suction of oropharynx, mouth and nose was done before the 
delivery of the shoulders by the obstetrician. Any mucus or meconium was 
aspirated. Pediatric resident postgraduate was called to attend the new born. 
After suctioning of the oropharynx and nasopharynx laryngoscopic 
visualization of the vocal cords was done by the pediatrician. The presence or 
absence of meconium below the vocal cords were evaluated and documented. 
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The staining of baby with meconium and 1 minute and 5 minute Apgar scores 
were observed and recorded. If the baby had respiratory distress or 5minute 
Apgar score less  than  6  then   baby  was  taken  to  neonatal   unit  and treated 
accordingly. 
After delivery patients were observed in labour ward for two hours and 
then shifted to postnatal ward. Any sign of puerperal pyrexia was watched for 
in the mother. 
Neonatal and maternal well being was monitored till the day of 
discharge from the hospital. 
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ANALYSIS OF STUDY OBSERVATION 
 
TABLE-1 
 
AGE IN YEARS 
 
Age Amnioinfusion Control 
18-20 24 28 
21-29 70 67 
>30 6 5 
P  = 0.79 NS 
 
In this study the age of the amnioinfusion group was matching with the 
control group. 
 
TABLE-2 
 
PARITY 
 
Parity Amnioinfusion Control 
Nullipara 65 61 
Paral 28 30 
Para2 7 9 
 
 
In this study parity of both the groups was matching. In both groups 
nulliparas were predominant and contributed to 65% of the study group and 61% 
of the control group  
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TABLE-3 
GESTATIONAL AGE 
Gestational Age Amnioinfusion Control 
37-40 Weeks 65 69 
40-41 Weeks 35 31 
P=0.55 NS 
 
The sample groups of amnioinfusion and control were matching in relation 
to their gestational age. Most of the patients were between 37-40 weeks of 
gestational age (65 in amnioinfusion and 69 in control group) 
 
TABLE-4 
PHASE OF LABOUR ON INCLUSION 
Phase Amnioinfusion Control 
Latent 36 31 
Active 64 69 
P=0.45NS 
In the amnioinfusion group 36 patients were in the latent phase of labour 
compared to 31 in the control group. In the control group 69 patients were in the 
active phase of labour compared to 64 in the amnioinfusion group 
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TABLE-5 
 
LABOUR CHARACTERISTICS 
 
Oxytocin Augmentation Amnioinfusion  (n=100) Control    (n=100) 
Present 37 31 
Absent 63 69 
Rupture of Membranes to 
delivery Interval (hrs) 
1.73 1.56 
 
Oxytocin augmentation was required in 37 patients in the amnioinfusion 
group and 31 patients in the control group. (P= 0.37 P value >.05 NS).  The mean 
interval from rupture of membranes to delivery was 1.73hours in the 
amnioinfusion group and 1.56 hours in the control group. This shows that there is 
no significant difference in the use of oxytocin for augmentation or in the duration 
of labour with amnioinfusion.  
 
TABLE-6 
INTRAPARTUM FOETAL HEART RATE ABNORMALITIES 
 
Bradycardia,  
Tachycardia 
Amnioinfusion n=100 
 
Control n=100 
 
Present 28 42 
Absent 72 58 
P=0.04S 
There were more cases of fetal distress in the control group (42%) 
compared with the amnioinfusion group (28%). P value is <. 05 This shows that 
amnioinfusion causes a significant reduction in the fetal heart rate abnormalities 
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during labour. 
TABLE-7 
 
MODE OF DELIVERY 
 
Nullipara Para l Para 2 Total 
Mode Amnio 
Infusion Control 
Amnio 
Infusion Control
Amnio 
Infusion Control 
Amnio 
Infusion Control 
Labour 
Natural 28 27 23 19 4 8 55 54 
Outlet 
Forceps 
 
4 5 - - - 1 4 6 
LMC 
forceps 
 
1 1 1 - 2 - 4 1 
LSCS 32 28 4 11 1 - 37 39 
 
 
When mode of delivery is considered 55 in the amnioinfusion group and 54 
in the control group delivered by labour natural. 4 patients in amnioinfusion group 
and 6 patient in the control group had outlet forceps delivery. Low midcavity 
forceps was used in 4 patients belonging to the amnioinfusion group and 1 patient 
in the control group. 37 patients in the amnioinfusion group and 39 patients in the 
control group were delivered by LSCS. (P value >.05). This shows that 
amnioinfusion is not influencing the mode of delivery in this study 
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TABLE-8 
RELATIONSHIP OF PHASE OF LABOUR TO MODE OF DELIVERY 
Amnioinfusion Control 
Latent: n=36 Active: n=64 Latent: n=31 Active: n=69 
Mode 
 
    Number %  Number %   Number % Number % 
Labour natural 6 16. 67 % 49 76.56% 6 19.35% 48 69.57%
Forceps -- -- 8 12.5% - - 7 10.14%
LSCS 30 83.33% 7 10.94% 25 80.65% 14 20.29%
 
Out of the 36 patients included in the amnioinfusion group in the latent 
phase, only 6(16.67%) delivered by labour natural. No  patient had forceps 
delivery, and caesarean was done for the majority of patients 30 (83.33%). In the 
control group there were 31 patients in the latent phase of labour. Out of these 
6(19.35%) delivered by labour natural and cesarean was done for the majority 
25(80.65%). 
In the amnioinfusion group 64 patients were in the active phase and 49 
(76.56%) of them delivered by labour natural. Forceps was applied for 8(12.5%) 
patients and only 7(10.14%) patients were taken for cesarean section. Out of the 
69 patients in the control group in the active phase of labour 48 (69.57%) 
delivered by labour natural, forceps was used for 7(10.14%) patients and cesarean 
was done only in 14(20.29%) patients. 
This shows that most of the patients with meconium stained amniotic fluid 
in the active phase of labour delivered by labour natural irrespective of whether 
amnioinfusion was given or not. And the patients that were included in the latent 
phase cesarean was the commonest mode of delivery in both the groups. 
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TABLE-9 
INTRAPARTUM OPERATIVE INTERVENTION 
 Amnioinfusion (n=100) Control (n=100) 
Forceps 8 7 
LSCS 37 39 
Total 45 46 
P= 0.94NS 
 
Regarding the number of intrapartum operative interventions, 45 in 
amnioinfusion group and 46 in the control group (P>.05) no significant decrease 
was seen with the use of amnioinfusion. When the incidence of LSCS alone was 
taken into consideration, it was 2% less in the amnioinfusion group. But this 
difference is not statistically significant. 
 
TABLE 10 
REASON FOR OPERATIVE INTERVENTION 
Reason  Amnioinfusion Control 
LSCS 18 31 
Forceps 2 4 Foetal Distress 
Total 20 35 
LSCS 19 8 
Forceps 6 3 Other 
Total 25 11 
P=0.05S  
When the reason for operative intervention was considered there was more 
number of cesareans for fetal distress in the control group than in the 
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amnioinfusion group (31 vs. 18 P<. 05). This difference is significant. The total 
number of operative interventions for fetal distress was 20 in the amnioinfusion 
group whereas it was 35 in the control group (P<. 05). These data shows that 
amnioinfusion decreases the incidence of operative interventions for fetal distress.   
 
TABLE-11 
NEONATAL  APGAR  SCORE 
Apgar score Amnioinfusion Control 
0-7 41 60 
1min 8-10 59 40 
0-7 13 24 
5min 8-10 87 76 
 
1 minute Apgar score <7 is seen in 41 infants in the amnioinfusion group 
and 60 infants in the control group. This difference is significant P value <. 05 .13 
infants belonging to the amnioinfusion group and 24 infants in the control group 
had <7 5 minute Apgar. This difference was also found to be significant with a P 
value of <. 05 Thus amnioinfusion has improved the Apgar of neonates at 1 
minute and at 5 minutes   
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TABLE-12 
BIRTH WEIGHT OF BABIES 
Weight in Kgs. Amnioinfusion Control 
2-2.5 30 29 
2.6-3.0 53 50 
>3 17 21 
Mean 2.77 2.78 
P=0.77NS  
The mean birth weight of the babies in the amnioinfusion and control group 
is almost equal 2.77 and 2.78. 
 
TABLE 13 
 
MECONIUM  BELOW  VOCAL  CORDS  AND  MECONIUM  
ASPIRATION SYNDROME 
 
Amnioinfusion Control 
MAS MAS 
Meconium 
below vocal 
cords Number  n=100 
No. % 
Number 
n=100 
No. % 
Present 20 4 20 36 15 41 
Absent 80 2 2.5 64 3 4.68 
 
Meconium below the vocal cords in direct laryngoscopy was found in 20 
neonates from the amnioinfusion group and 36 neonates from the control group. 
(P= 0.01P value<.05) there is a significant reduction in the number of neonates 
with meconium below the level of vocal cords in the amnioinfusion group. In the 
amnioinfusion group 6 neonates developed meconium aspiration syndrome 
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compared to 18 in the control group. There is a significant reduction in the 
incidence of meconium aspiration   syndrome      (P=0.01Pvalue<.05) in the 
amnioinfusion group Meconium aspiration syndrome developed in 2 (2.5%) of the 
neonates in the amnioinfusion group who did not have meconium at the level of 
vocal cords compared to 3(4.68%) in the control group.  
 
TABLE 14 
REASONS FOR NEONATAL UNIT ADMISSION 
Reason Amnioinfusion Control 
Meconium smeared baby for 
observation 9 14 
Meconium aspiration syndrome 6 18 
Hypoxic ischaemic encephalopathy 1 I 
Birth asphyxia 4 5 
Total 20 38 
 
20 babies from the amnioinfusion group and 38 babies from the control 
group were admitted in the neonatal unit. In the control group meconium 
aspiration syndrome is the predominant indication for admission. There was one 
baby with hypoxic ischaemic encephalopathy from each group. 4 babies from 
amnioinfusion group and 5 babies from the control group had birth asphyxia.  
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TABLE 15. 
DURATION OF NEONATAL UNIT ADMISSION 
Amnioinfusion Control 
No of days 
Number 
n =20 % 
Number 
n=38 % 
1-4 14 70% 25 65.79% 
5-10 5 25% 11 28.95% 
>10 1 5% 2 5.26% 
Mean 3.2  3.6  
 
The mean duration of stay in the neonatal unit was 3.2 days in the 
amnioinfusion group and 3.6 days in the control group. This difference was not 
significant statistically.  
TABLE 16 
PERINATAL MORTALITY RATE AND MORBIDITY RATE 
 
 Amnioinfusion Control 
Mortality 1/100 3/100 
Morbidity 20 38 
 
Perinatal mortality was one in the amnioinfusion group and three in the 
control group. One baby in the amnioinfusion group died after 1 days in the 
neonatal unit. That baby was diagnosed to have hypoxic ischaemic 
encephalopathy stage III.  At birth itself the baby had low Apgar scores both at 1 
minute and 5 minute. The baby also showed the presence of meconium below the 
vocal cords at birth. Among the control group 3 babies died in the neonatal 
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period. One baby died due to ischaemic encephalopathy stage III on the Fifth day. 
Two  babies had  meconium aspiration syndrome and died on the First day.  The 
perinatal morbidity is significantly reduced in the amnioinfusion group20 versus 
38 in the control Group. P Value <.05 
 
 
TABLE 17 
MATERNAL COMPLICATION 
 
Puerperal Pyrexia Amnioinfusion (n=100) Control (n=100) 
Present 2 6 
Absent 98 94 
 
2 patients in the amnioinfusion group had fever compared to six patients in 
the control group. There was no significant difference in the maternal 
complication between the two groups. 
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DISCUSSION 
 
In this study 100 patients received amnioinfusion and 100 patients did not 
receive amnioinfusion for moderate and thick meconium stained amniotic fluid. 
The amnioinfusion group and control group were matched with respect of 
age, parity and gestational age. More patients in amnioinfusion group were in the 
latent phase of labour on inclusion but this difference was not significant. 
The number of patients receiving oxytocin for labour augmentation is not 
influenced by amnioinfusion (37% vs. 31% P value >.05). In the study by Usta et 
al27 the amnioinfusion group had significantly higher incidences of oxytocin use 
than the control group (44% vs. 23% P<. 001). The study by Cialone et al23 also 
showed the patients receiving amnioinfusion had greater oxytocin requirement in 
labour. 
In this study there is no statistically significant difference between the two 
groups in the rupture of membranes to delivery interval( 1.73 hrs vs. 1.56 hrs). 
This is correlating with the study by Cialone et al23 in which the rupture of 
membrane to delivery interval was similar in both groups. Usta et al27 showed 
longer mean rupture to delivery interval in the amnioinfusion group. 
The incidence of fetal distress in this study was 28% in the amnioinfusion 
group and 42% in the control group. (P<. 05) This is in par with Wenstrom8 and 
Parsons study which showed decrease incidence of fetal distress in the 
amnioinfused patient. But in contrast the study by Rogers et al20showed a higher 
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incidence of fetal distress in the amnioinfused group. (30.5% vs. 19.7%) Erikson 
et al22 also demonstrated that the incidence of fetal distress was not significantly 
different between the two groups in contrast to this study. 
In both the groups in this study most of the patients included in the latent 
phase of labour delivered by caesarean section while most of the patients included 
in the active phase of labour delivered vaginally 
There was no significant difference between the two groups regarding the 
mode of delivery. Results from other studies on the effect of intrapartum 
amnioinfusion on cesarean rates are given in table 18.   
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TABLE 18 
 
INTRAPARTUM AMNIOINFUSION AND CESAREAN RATES 
 
Study Amnioinfusion Control 
Spong et al 1994 8/43 (18.6) 9/50 (18.0) 
Cialone et al 1994 14/47 (29.8) 11/58 (19.0) 
Khosla et al 1997 1/25 (4.0) 7/25 (28.0) 
Hofmeyr et al 1998 70/167 (41.9) 68/159 (42.8) 
Mahomed et al 1998 30/317 (9.5) 37/328 (11.3) 
Moodley et al 1998 3/30 (10.0) 7/30 (23.0) 
A.M Rathor et al 2002 21/100 (21.0) 36/100 (36.0) 
Parthe Mukhopadhyay et al 2006 18/93 (19.3) 39/93 (41.5) 
Das A.K. et al 2007 18/100 (18) 30/100 (30) 
 
The last three studies mentioned in table 18-show reduction in the cesarean 
section rate with amnioinfusion while other studies do not show a significant 
difference.  
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In this study the number of operative deliveries for fetal distress was 
significantly lower than that in control group (18% vs.31% P<. 05). This is similar 
to the result in the study by A.M.Rathore et al44, (12% vs. 26%). Parthe 
Mukhopadhyay et al51 (19.3% vs. 41.5%). Lo and Rogers20, Moodley et al36 and 
Marci et al19 also reported similar findings. Eriksen et al22 and Sponge et al26 
reported no effect on caesarean section for fetal distress. Usta  et al 27 reported a 
higher incidence of caesarean delivery in the amnioinfusion group. (28% vs. 17%) 
especially for fetal distress (16% vs. 11%) The CRAMP 1 and 234,35 also showed 
no significant difference in the caesarean section rates for fetal distress between 
the two groups.  
In this study the 1-minute Apgar rate of < 7(41% vs.60% P<.05) and 5-
minute Apgar rate of <7 (13% vs.24% P<.05) was significantly lower in the 
amnioinfusion group. Parthe Mukhopadhyay et al51 (1min4.2%vs 11.5%; 5min 
2.1% vs 6.3%)  A.M. Rathore et al 44. (1 min 2% vs. 8%; 5 min 1% vs. 2%) 
reported similar findings in their studies. The Studies by Wenstrom8 and Parson, 
Marci et al19, Keith and Rogers all showed a significant decrease in the number of 
babies with low Apgar in the amnioinfusion group. This is in contrast with the 
study of Usta et al27, which showed no significant difference between the Apgar 
scores of the two groups.  
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There was no significant difference in the birth weight of the babies from 
the amnioinfusion and control groups (2.77 vs.2.78). In the study by Usta et al27 
the mean birth weight was significantly higher in the amnioinfusion group.  
In this study the presence of meconium below the level of vocal cord is 
significantly reduced in the amnioinfusion group (20% vs. 36% P<. 05). The 
incidence in other studies is given in Table 19.  All the studies show a reduction in 
the incidence of meconium below the level of vocal cords with amnioinfusion 
except that of Sponge et al26 Usta et al27
The incidence of meconium aspiration syndrome in this study was 6 in the 
amnioinfusion group versus 18 in the control group. (P<.05).  This shows that 
there is significant decrease in the incidence of meconium aspiration syndrome in 
the group that received amnioinfusion. Other studies showing similar results are 
given in table 20. All the studies show decrease in the incidence of meconium 
aspiration syndrome with amnioinfusion.  
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TABLE 19 
 
INTRAPARTUM AMNIOINFUSION AND PRESENCE OF MECONIUM 
BELOW THE VOCAL CORDS 
 
Study 
Amnioinfusion 
Group n (%) 
Control 
Group n (%) 
Sadovsky et al 1989  0/19 (0.0) 6/21 (28.6) 
Macri et al 1992  4/85 (4.7) 33/85 (38.8) 
Spong et al 1994  3/43 (7.0) 2/50 (4.0) 
Cialone et al 1994  2/47 (4.2) 34/58 (58.6) 
Eriksson et al 1994  1/65 (1.5) 8/59 (13.6) 
Usta et al 1995  28/97 (29.0) 31/112 (28.0) 
Hofmeyr et al 1998  6/158 (3.8) 12/164 (7.3) 
Khosla et al 1997  3/25 (12.0) 4/25 (16.0) 
A.M Rathor et al 2002  10/100 (10.0) 24/100 (24.0) 
Sood M et al 2004 17/100 (17.0) 48/100 (48.0) 
Parthe Mukhopadhyay et al 2006 6/93 (6.3) 34/93 (35.76) 
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TABLE 20 
 
INTRAPARTUM AMNIOINFUSION AND MECONIUM  
ASPIRATION SYNDROME 
 
Study Amnioinfusion 
Group n(%) 
Control 
Group n (%) 
Wenstrom et al 1989 0/36 (0.0) 3/44 (6.8) 
Macri et al 1992 0/85 (0.0) 5/85 (5.9) 
Lo and Rogers et al 1993 1/60(1.7) 3/52 (5.8) 
Cialone et al 1994 1/47 (2.1) 6/58 (13.6) 
Erikson et al 1994 0/65 (0.0) 2/59 (3.4) 
Usta et al 1995 19/497 (3.8) 20/440 (4.5) 
Mahomed et al 1998 10/323 (3.1) 42/329 (12.8) 
A.M. Rathor et al 2002 0/100 (0) 1/100 (1.0) 
Partha Mukhopadhyay et al 2006 2/100 (2) 9/100 (9) 
Das AK et al 2007 4/100 (4) 18/100 (18) 
 
In this study 20 neonates from the amnioinfusion group and 38 from the 
control group needed admission in the neonatal unit. This shows that there is a 
significant decrease in the neonatal admissions in the amnioinfusion group. (20% 
vs. 38% P<. 05)  
CRAMP 2 Zimbabwe arm35 showed similar results (12.8% vs.22.9%). The 
study by A.M.Rathore et al44 also showed decreased neonatal admissions in the 
amnioinfusion group. (3% vs. 11%) Studies by Eriksson et al 22 Cialone et al23 and 
CRAMP 1 South African arm34 also showed similar results.  
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In this study Hypoxic ischaemic encephalopathy occurred in 1 baby from 
each group. In the study by Moodley et al36 hypoxic ischaemic encephalopathy 
occurred in none of the babies from the amnioinfusion group while 2 babies in the 
control group had neonatal hypoxic ischaemic encephalopathy.  
The duration of stay in the neonatal unit was not significantly different in 
both the groups. This is similar to the study by Sponge et al 3.5 days in the 
amnioinfusion group versus 3.6 days in the control group. In this study the mean 
duration of stay in the neonatal unit was 3.2 days in the amnioinfusion group and 
3.6 days in the control group.  
The perinatal mortality rate in the amnioinfusion group is 1% while in the 
control group it is 3%. The difference is not  significant statistically. In the 
CRAMP 2 study35 conducted in Zimbabwe, the perinatal mortality was 1.2% in 
the amnioinfusion group and 3.6% in the control group. In the study by A.M. 
Rathore et al44. the perinatal mortality rate was 2% in the amnioinfusion group  
versus 5% in the control group. Das AK et al showed a perinatal mortality rate of 
4% in the amnioinfusion group and 13% in the control group. 
There were no increased puerperal complications in the amnioinfusion 
group. The incidence of puerperal pyrexia was 2% in the amnioinfusion group and 
6% in the control group. This reduction was not statistically significant. In the study 
by A.M.Rathore et al44 there was significantly reduced incidence of puerperal pyrexia 
in the amnioinfusion group. (6% vs. 12%) The studies by Wenstrom et al8, 
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Sadovsky et al9, Marci et al19, have showed no increase in the maternal morbidity 
in the amnioinfusion group. 
In this study no adverse effect was noted in the fetus or mother due to 
amnioinfusion. 
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SUMMARY 
200 patients with moderate or thick meconium stained amniotic fluid were 
selected from labour ward in this prospective case controlled study. 100 of them 
were allotted to the amnioinfusion group and 100 were kept as control and received 
no amnioinfusion. 
In analyzing the intrapartum course and the perinatal outcome, the following 
points were summed up. 
1) Majority of patients in the amnioinfusion and control group were in the age 
group of 18-30. Only 6% in the amnioinfusion and 5% in the control group were 
above 30. 
2) In both groups nullipara were predominant and contributed to 65%of the 
selected sample group in amnioinfusion and 61% of the selected sample group 
in control group. 
3) The gestational age for majority of the patients in both the amnioinfusion and 
control group was between 37-40 weeks. Only 35% in the amnioinfusion group 
and 31% from the control group had gestational age above 40 weeks. 
4) At the time of  inclusion, majority of the patients were in the active phase of 
labour - 64% in the amnioinfusion group and 69% in the control group. 
 
5) Augmentation was needed in 37% patients in the amnioinfusion group and 31% 
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patients in the control group. 
6) The mean duration of labour from rupture of membranes to delivery was 1.73 
hours in the amnioinfusion group and 1.56 hours in the control group. This 
difference is not significant and this shows that in this study there was no effect 
on the duration of labour by amnioinfusion. 
7) The incidence of intrapartum fetal heart rate abnormalities was significantly 
lower in the amnioinfusion group.28% versus 42%. 
8) Regarding the mode of delivery majority in both groups delivered by labour 
natural - 55% in the amnioinfusion group and 54% in the control group. The 
incidence of operative vaginal deliveries was 8% in the amnioinfusion group 
and 7% in the control group. 
9) The number of patients who delivered by cesarean section was 37% in the 
amnioinfusion group and 39% in the control group. This difference was not 
significant. 
10) There was significant decrease in the number of cesareans done for fetal 
distress in the amnioinfusion group. 18% versus 31% in the control group. 
11) Most of the patients who were included in this study in the active phase of 
labour delivered vaginally while most of the patients who were included in the 
latent phase underwent cesarean section. 
12) On summing up the data about the perinatal outcome, there was significant 
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decrease in the incidence of 1 minute and 5 minute Apgar scores less than 7 in 
the amnioinfusion group. 1 minute Apgar 41% in the amnioinfusion 
versus 60% in the control; 5 minute Apgar 13% in the amnioinfusion versus 
24% in the control. 
13) The mean weight of the babies was 2.77 in the amnioinfusion group and 2.78 in 
the control group. 
14) The presence of meconium below the vocal cords was significantly reduced in 
the amnioinfusion group 20% versus 36% in the control group. 
15) The incidence of meconium aspiration syndrome was also significantly reduced 
in the amnioinfusion group. 6% versus 18% in the control group. This shows that 
amnioinfusion is effective in reducing meconium aspiration syndrome in cases of 
meconium stained amniotic fluid. 
16) Number of babies admitted to the neonatal unit was 20% from the 
amnioinfusion group and 38% from the control group. There is significant 
reduction in the neonatal admission with the use of amnioinfusion. 
17) There was no significant difference in the duration of neonatal unit stay between 
the two groups. 3.2 days in the amnioinfusion group and 3.6 days in the control 
group. 
 
18) Perinatal mortality was one in the amnioinfusion group and three in the control 
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group. 
19) There were no increased puerperal complications in women who received 
amnioinfusion - 2% in the amnioinfusion group and 6% from the control group 
had puerperal pyrexia. 
20) There were no adverse maternal or fetal complications reported with 
amnioinfusion in this study. 
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CONCLUSION 
In  this  study  it  has  been  found that the use of amnioinfusion has 
significantly reduced the number of intrapartum fetal heart abnormalities. 
It is not affecting the mode of delivery in patients with meconium stained 
amniotic fluid in labour. The incidence of cesarean delivery is not reduced but the 
number of cesareans done for fetal distress has decreased by the use of amnioinfusion. 
The results show a striking improvement in the perinatal outcome in the 
patients who received amnioinfusion. There was significant improvement in the 1 
minute and 5 minute Apgar scores, decrease in the incidence of meconium 
detected below the level of vocal cords and decrease in meconium aspiration 
syndrome. The number of babies admitted in the neonatal unit is also significantly 
reduced in the amnioinfusion group. 
In the mother there was no complications related to amnioinfusion  and 
there  was  no significant difference  in  the puerperium. 
To  conclude  amnioinfusion   is  a  safe,   easy  and effective procedure that 
needs little expertise and can be done in labour wards with even limited facilities. 
The use of such simple technique will not only reduce the burden on already 
limited resources in developing countries but will also have cost benefits. 
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ABBREVIATIONS 
 
LN   - Labour Natural  
LSCS   - Lower Segment cesarean section 
LMC Forceps - Low mid cavity forceps 
FD   - Fetal Distress 
NICU   - Neonatal Intensive Care Unit 
MAS   - Meconium Aspiration Syndrome 
HIE   - Hypoxic Ischaemic encephalopathy  
BA   - Birth Asphyxia 
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PROFORMA 
 
Case Number : 
Name :    Age :   I.P. No. 
Obstetric Formula : 
Menstrual Cycles :   Regular / Irregular 
LMP :    EDD :    GA Weeks : 
Height :    Weight : 
PR :    BP  :  Pallor  : 
Pedal Edema :   CVS  :  RS : 
P/A Uterine Size:   Cephalic :  Acting / not acting : 
Fetal Heart Rate : 
Rupture of membranes:  date  :  time :  
P/V cervical effacement  dilatation  :  Station : 
Pelvis  :    Degree of meconium : 
Time of start of amnioinfusion : 
Oxytocin augmentation : Yes / No 
Intrapartum fetal distress : Yes / No 
Delivery   : Date  :  Time : 
Mode  of delivery  : Natural/LSCS/LMC/Outlet Forceps  
Indication for LSCS / Forceps : Fetal Distress / others 
70 
Rupture of membranes to delivery interval:   
Baby    : Alive / asphyxiated / dead born Sex : M / F 
Apgar  1 min    5 min   Baby Weight  
Meconium below the vocal cord: Yes / No 
Admission to NICU  : Yes / No 
Reason for Admission :   Observation / MAS / BA / HIE 
Duration of NICU Stay :  
Condition on discharge : 
Maternal Complications :  
 
 
 
